Daybue (Trofinetide) is the first FDA-approved prescription treatment for Rett syndrome in individuals aged 2 and older, aiming to improving symptoms like communication, motor skills, and mood, though it’s often associated with significant diarrhea. It’s an oral solution requiring careful management for side effects.